published a meta-analysis of gene expression profiles with three gene modules (proliferation, ER signaling and ERBB2 amplification) in 2833 breast tumor to better understand cancer subtyping and prognosis signatures (63). This evidence concerns the gene ERBB2 and breast neoplasm.